These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 2457315

  • 21. Oral acyclovir suppression of recurrent genital herpes: a double-blind, placebo-controlled, crossover study.
    Halsos AM, Salo OP, Lassus A, Tjøtta EA, Hovi T, Gabrielsen BO, Fiddian AP.
    Acta Derm Venereol; 1985; 65(1):59-63. PubMed ID: 2578707
    [Abstract] [Full Text] [Related]

  • 22. An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients.
    Fife KH, Warren TJ, Justus SE, Heitman CK, HS2100275 STUDY TEAM.
    Sex Transm Dis; 2008 Jul; 35(7):668-73. PubMed ID: 18461016
    [Abstract] [Full Text] [Related]

  • 23. Oral acyclovir suppressive therapy in severe recurrent genital herpes. A double-blind, placebo-controlled cross-over study.
    Kroon S, Petersen CS, Andersen LP, Rasmussen LP, Vestergaard BF.
    Dan Med Bull; 1989 Jun; 36(3):298-300. PubMed ID: 2666040
    [Abstract] [Full Text] [Related]

  • 24. Long-term suppressive therapy with acyclovir for recurrent genital herpes.
    Baker DA.
    J Int Med Res; 1994 Jun; 22 Suppl 1():24A-31A; discussion 31A-32A. PubMed ID: 8063021
    [Abstract] [Full Text] [Related]

  • 25. Inosine pranobex.
    Glasky AJ, Galli M, Lassus A, Salo O.
    Lancet; 1985 May 11; 1(8437):1103-4. PubMed ID: 2582218
    [No Abstract] [Full Text] [Related]

  • 26. Efficacy of acyclovir in the treatment of recurring herpes labialis, genitalis and acute herpes zoster.
    Peralta S, Ribisi La Spina AM, Pirrotta P, Collura D, Formica P, Tinnirello D, Citarrella P, Mansueto S.
    J Chemother; 1989 Jul 11; 1(4 Suppl):1117-8. PubMed ID: 16312797
    [No Abstract] [Full Text] [Related]

  • 27. Efficacy of acyclovir combined with immunopotentiating agents in the treatment of varicella-zoster.
    Tanphaichitra D, Srimuang S.
    J Antimicrob Chemother; 1987 Feb 11; 19(2):255-62. PubMed ID: 2437095
    [Abstract] [Full Text] [Related]

  • 28. Update on acyclovir: oral therapy for herpesvirus infections.
    True BL, Carter BL.
    Clin Pharm; 1984 Feb 11; 3(6):607-13. PubMed ID: 6096075
    [Abstract] [Full Text] [Related]

  • 29. Genital herpes--when and how to treat.
    Kroon S.
    Semin Dermatol; 1990 Jun 11; 9(2):133-40. PubMed ID: 2202409
    [Abstract] [Full Text] [Related]

  • 30. Inosiplex in recurrent herpes simplex infection.
    Abeles JH.
    Lancet; 1982 Oct 23; 2(8304):926. PubMed ID: 6181365
    [No Abstract] [Full Text] [Related]

  • 31. Valacyclovir for the treatment of genital herpes.
    Brantley JS, Hicks L, Sra K, Tyring SK.
    Expert Rev Anti Infect Ther; 2006 Jun 23; 4(3):367-76. PubMed ID: 16771614
    [Abstract] [Full Text] [Related]

  • 32. Clinical and immunological assessment in HIV+ subjects receiving inosine-pranobex. A randomised, multicentric study.
    De Simone C, Albertini F, Almaviva M, Angarano G, Chiodo F, Costigliola P, Delia S, Ferlini A, Gritti F, Mazzarello G.
    Med Oncol Tumor Pharmacother; 1989 Jun 23; 6(1):63-7. PubMed ID: 2471025
    [Abstract] [Full Text] [Related]

  • 33. A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis. Valaciclovir HSV Study Group.
    Spruance SL, Tyring SK, DeGregorio B, Miller C, Beutner K.
    Arch Intern Med; 1989 Jun 23; 156(15):1729-35. PubMed ID: 8694673
    [Abstract] [Full Text] [Related]

  • 34. Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract.
    Gupta R, Wald A, Krantz E, Selke S, Warren T, Vargas-Cortes M, Miller G, Corey L.
    J Infect Dis; 2004 Oct 15; 190(8):1374-81. PubMed ID: 15378428
    [Abstract] [Full Text] [Related]

  • 35. The efficacy of inosine pranobex in preventing the acquired immunodeficiency syndrome in patients with human immunodeficiency virus infection. The Scandinavian Isoprinosine Study Group.
    Pedersen C, Sandström E, Petersen CS, Norkrans G, Gerstoft J, Karlsson A, Christensen KC, Håkansson C, Pehrson PO, Nielsen JO.
    N Engl J Med; 1990 Jun 21; 322(25):1757-63. PubMed ID: 1693173
    [Abstract] [Full Text] [Related]

  • 36. [Immunological and clinical study on therapeutic efficacy of inosine pranobex].
    Gołebiowska-Wawrzyniak M, Markiewicz K, Kozar A, Derentowicz P, Czerwińska-Kartowicz I, Jastrzebska-Janas K, Wacławek J, Wawrzyniak ZM, Siwińska-Gołebiowska H.
    Pol Merkur Lekarski; 2005 Sep 21; 19(111):379-82. PubMed ID: 16358878
    [Abstract] [Full Text] [Related]

  • 37. Long-term acyclovir suppression of frequently recurring genital herpes simplex virus infection. A multicenter double-blind trial.
    Mertz GJ, Jones CC, Mills J, Fife KH, Lemon SM, Stapleton JT, Hill EL, Davis LG.
    JAMA; 1988 Jul 08; 260(2):201-6. PubMed ID: 3290517
    [Abstract] [Full Text] [Related]

  • 38. Inosine pranobex. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
    Campoli-Richards DM, Sorkin EM, Heel RC.
    Drugs; 1986 Nov 08; 32(5):383-424. PubMed ID: 2431857
    [Abstract] [Full Text] [Related]

  • 39. Dosage and safety of long-term suppressive acyclovir therapy for recurrent genital herpes.
    Mindel A, Faherty A, Carney O, Patou G, Freris M, Williams P.
    Lancet; 1988 Apr 23; 1(8591):926-8. PubMed ID: 2895840
    [Abstract] [Full Text] [Related]

  • 40. Immunotherapy of genital warts with inosine pranobex and conventional treatment: double blind placebo controlled study.
    Davidson-Parker J, Dinsmore W, Khan MH, Hicks DA, Morris CA, Morris DF.
    Genitourin Med; 1988 Dec 23; 64(6):383-6. PubMed ID: 2465265
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.